In 1973 a mental health practitioner would have to read 3 research papers per day to stay up to date on the latest high quality research. By 2013 that number rose to 249 papers per day.
André Tomlin, The Mental Elf
Alzheimers prescribing
Findings and implications: Cholinesterase inhibitors were effective for severe Alzheimer’s disease These findings are inconsistent with the literature on which NICE guidance was based (due to be updated in 2014) which recommends AChE inhibitors, such as donepezil, for mild to moderate Alzheimer’s disease and memantine for severe disease. This study recommends treatment with cholinesterase inhibitor should be considered in the awareness of the increased risks of adverse outcomes including syncope, the need for permanent pacemakers and hip fractures.
Back to search